Tech Company Financing Transactions
BioRelix Funding Round
On 6/4/2007, BioRelix raised $25.8 million in Series B funding from Aisling Capital, CHL Medical Partners and Elm Street Ventures.
Transaction Overview
Company Name
Announced On
6/4/2007
Transaction Type
Venture Equity
Amount
$25,750,000
Round
Series B
Investors
Proceeds Purpose
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Winchester Ave.
New Haven, CT 06511
USA
New Haven, CT 06511
USA
Phone
Website
Email Address
Overview
BioRelix is engaged in the discovery and development of anti-biotic drug candidates for the treatment of infectious diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joel Marcus
Browse more venture capital transactions:
Prev: 6/4/2007: Innovative Metabolics venture capital transaction
Next: 6/5/2007: GuestCentric Systems venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs